Financhill
Back

BioXcel Therapeutics Stock Predictions

BioXcel Therapeutics Stock Forecast

  • Is BioXcel Therapeutics Stock Undervalued?
    The current BioXcel Therapeutics [BTAI] share price is $0.66. The Score for BTAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will BioXcel Therapeutics Stock Go Up Next Year?

Data Unavailable

BioXcel Therapeutics Stock Rating

Data Unavailable

BioXcel Therapeutics Stock Price History

Is BTAI stock going to rise?

  • The current trend is relatively stagnant and BTAI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bioxceltherapeutics.com

52-Week Data

52-Week High:
5.62
52-Week Low:
0.53

Prediction Charts

Market Cap:
26.9M
Price in USD:
0.66
Volume:
404.69K
Beta:
0.76

Technical Analysis

SMA50:
0.84
SMA100:
1.28
SMA200:
2.12
52-Wk Change:
-78.84%

Stock Predictions

  • Is BioXcel Therapeutics stock public?
    Yes, BioXcel Therapeutics is a publicly traded company.
  • What is the BioXcel Therapeutics stock quote today?
    The BioXcel Therapeutics stock price is 0.66 USD today.
  • How to buy BioXcel Therapeutics stock online?
    You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 0.63 0.62 0.63 0.59
Sep-3 0.63 0.62 0.64 0.60
Sep-4 0.62 0.60 0.63 0.59
Sep-5 0.61 0.59 0.62 0.58
Sep-6 0.59 0.54 0.61 0.54
Sep-9 0.57 0.55 0.58 0.55
Sep-10 0.59 0.54 0.59 0.53
Sep-11 0.54 0.54 0.56 0.53
Sep-12 0.56 0.55 0.57 0.54
Sep-13 0.56 0.68 0.68 0.56
Sep-16 0.72 0.64 0.84 0.64
Sep-17 0.63 0.63 0.66 0.63
Sep-18 0.64 0.64 0.67 0.63
Sep-19 0.63 0.66 0.67 0.63

BioXcel Therapeutics Earnings

Data Unavailable

BioXcel Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.12 per share, an increase this year of $4.08 per share, and an increase next year of $0.47 per share.

* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.